INS and diabetic kidney disease: We previously reported that RAS components in the kidney were already upregulated at a young age in OLETF rats and that angiotensin AT1 receptor blockade during the prediabetic stage of OLETF rats (4 to 11 weeks of age) prevented the development of diabetic nephropathy in later life without marked effects on body weight, blood glucose, or plasma insulin levels [11].